TAITRON COMPONENTS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TAITRON COMPONENTS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $4.14M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $6.11M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $8.42M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $8.64M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $6.70M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $6.78M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $8.22M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $7.62M | Apr 1, 2019 |
| FY2013 | Dec 31, 2013 | $6.27M | Mar 31, 2014 |
| FY2013 | Dec 31, 2012 | $7.19M | Mar 31, 2014 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $7.62M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $6.92M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $5.67M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $5.82M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $6.27M | Mar 31, 2015 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.12M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $3.45M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $4.39M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $4.12M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.28M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $3.08M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.62M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $3.00M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($748.0K) | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $1.76M | Mar 31, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $902.0K | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $1.85M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $3.21M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $2.01M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.36M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $773.0K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.38M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $701.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($3.11M) | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | ($587.0K) | Mar 31, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($104.0K) | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $1.20M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.24M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $2.09M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.05M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $698.0K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.42M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $791.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($2.87M) | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | ($339.0K) | Mar 31, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.22M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $2.25M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.16M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $2.03M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $2.23M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $2.38M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $2.20M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $2.21M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $2.12M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $2.10M | Mar 31, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($258.0K) | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $3.15M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.69M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.74M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $2.05M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $1.41M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $2.29M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $388.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.25M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $274.0K | Mar 31, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $232.0K | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $215.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.0K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $18.0K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $17.0K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $17.0K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $5.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $37.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $4.0K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $37.0K | Mar 31, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $17.64M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $18.01M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $17.14M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $17.12M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $14.26M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $13.60M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $13.98M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $13.57M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $13.88M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $18.05M | Mar 31, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $2.74M | Mar 31, 2022 |
| FY2021 | Dec 31, 2020 | $1.02M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $784.0K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.28M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $1.71M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $2.20M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $2.84M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $2.14M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $2.36M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $2.60M | Mar 31, 2014 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $16.56M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $16.84M | Mar 31, 2025 |
| FY2024 | Dec 31, 2022 | $16.14M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $14.39M | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | $13.24M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $12.72M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $12.60M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $11.76M | Mar 30, 2020 |
| FY2017 | Dec 31, 2016 | $11.58M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $15.10M | Mar 31, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $5.12M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $5.42M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $4.78M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $3.28M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $2.23M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $1.71M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.66M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $867.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $720.0K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $4.25M | Mar 31, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $4.21M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $6.21M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $5.22M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $5.97M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $6.65M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $5.31M | Mar 31, 2021 |
| FY2020 | Dec 31, 2018 | $4.49M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $3.25M | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $4.02M | Apr 1, 2019 |
| FY2017 | Dec 31, 2015 | $3.69M | Apr 2, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 0 | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | 0 | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Apr 1, 2013 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 0 | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | 0 | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Apr 1, 2013 |